Oncology investment & partnering trends

Pharma investment in oncology is far and above all other therapeutic areas, with dealmaking and partnering a core strategy in that investment. In just the last 4 years, oncology deal values totaled a whopping $331 billion. From the top 20 pharma companies to small start-ups, oncology is pulling investment from across life sciences.

This webinar dives into pharma’s largest sector to examine:

• The most recent oncology deals activity, including a look at deal types, volume, regulatory designation, and phase
• The most prevalent and emerging technologies
• Competitive landscape for the top 10 oncology licensing deals
• Private and VC investment activity across the oncology landscape
• Best practices for partnering